NGeneBio Co Ltd (354200) Stock Price & News

Why is 354200 up 3.13%?

Dive Deeper

354200:KOSDAQ

NGeneBio Co Ltd

₩856.00

+3.13%

(+26.00) 1D

Nov 13, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 354200...

Open

₩830

High

₩990

Low

₩800

Mkt. cap

13.77B

Avg. vol.

2.21M

Volume

2.66M

52-wk high

₩6,980

52-wk low

₩590

EPS

-₩1,121

Shares outstanding

16.09M

No. of employees

Open

₩830

High

₩990

Low

₩800

Mkt. cap

13.77B

Avg. vol.

2.21M

Volume

2.66M

52-wk high

₩6,980

52-wk low

₩590

EPS

-₩1,121

Shares outstanding

16.09M

No. of employees

Related stocks

Selvas Healthcare Inc

News stories

From web sources and news partners

Yahoo Finance

57 minutes ago

Stock market today: Dow, S&P 500, Nasdaq futures waver as Nvidia tumult deepens

Reuters

51 minutes ago

Nasdaq futures dip as Nvidia tumult keeps investors on edge

FOREX.com

19 minutes ago

S&P 500 forecast: SPX struggles for direction ahead of PPI data

CNBC

55 minutes ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

About NGeneBio Co Ltd

CEO-

Employees57

Founded2015

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitengenebio.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.43B	11.97B	11.95B	12.45B
Cost of goods sold	4.40B	10.51B	10.54B	10.57B
Cost of revenue	4.40B	10.51B	10.54B	10.57B
Research and development expenses	339.50M	358.78M	328.91M	402.52M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.96B	2.57B	2.38B	2.52B
Operating expense	2.68B	3.36B	2.97B	3.07B
Total operating expenses	7.08B	13.88B	13.52B	13.64B
Operating income	-1.65B	-1.90B	-1.57B	-1.19B
Other non operating income	-21.71M	351.37M	-1.84B	-1.07B
EBT including unusual items	-1.90B	3.70B	-4.18B	-3.46B
EBT excluding unusual items	-1.86B	-2.43B	-4.36B	-3.35B
Income tax expense	-	-965.45M	-	-
Effective tax rate	-	-26.10%	-	-
Other operating expenses	61.39M	89.96M	53.98M	61.73M
Net income	-1.90B	4.48B	-4.17B	-3.45B
Net profit margin	-34.92%	37.41%	-34.92%	-27.71%
Earnings per share	-	-	-	-
Interest and investment income	-2.06M	33.33M	21.11M	83.05M
Interest expense	-274.25M	-974.81M	-1.17B	-1.24B
Net interest expenses	-276.31M	-941.48M	-1.15B	-1.16B
Depreciation and amortization charges	116.08M	118.65M	132.82M	86.93M
EBITDA	-1.27B	-1.51B	-1.21B	-869.93M
Gain or loss from assets sale	13.89M	27.34M	-311.57M	29.00K

Ask anything